• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

How to love and care for cocker spaniel ears (Proceedings)

April 1, 2009
Marcia Schwassman, DVM, DACVD

Cocker spaniels have higher yeast carriage in the ear and it may be easier for the yeast to cause disease.

I. Popularity

II. Reaction to treatment

III. Gross anatomy

a. Pendulous

i. Aerate and examine ears

b. Heavily haired

i. Keep hair trimmed as short as possible

IV. Microscopic Anatomy

a. Significantly more ceruminous glands

i. Use ceruminolytic and drying agents regularly

b. High density compound hair follicles

i. Grooming

II. No powders

III. Use anti-inflammatories after pulling hair

V. Atopy

a. Treat systemically

b. Use acidifying/drying agents on a regular basis

c. Use topical steroids

VI. Seborrhea and Hypothyroidism

a. Treat underlying disease

b. Vitamin A: 600 to 800 IU/kg/day

c. Levothyroxine

d. Ceruminolytic agents

e. Topical steroids

VII. Malassezia

a. Cockers produce more cerumen with higher fatty acid content

b. Malassezia attach to corneocytes via lipid

c. Therefore Cockers have higher yeast carriage in the ear and it may be easier for the yeast to cause disease.

d. Treatment

i. Ceruminolytic agents

II. Topical steroids

III. Drying/acidifying agents

Advertisement

IV. Topical antifungals

1. Ketoconazole (T8 Keto Flush®), Clotrimazole, Miconazole (Conofite®, Malaseb® flush)

v. Systemic antifungals

1. Ketoconazole (5-10 mg/kg daily)

2. Itraconazole (5 mg/kg daily or 2 days a week)

3. Fluconazole (5 mg/kg daily)

VIII. Exuberant Reaction to Inflammation

a. In most studies, Cockers far outnumber any other breed that needs surgical removal of the ears.

b. Cockers have a different type of tissue reaction to otic inflammation.

i. Most dogs breeds have slowly progressive fibrotic changes

II. Cockers have rapidly progressive, severe ceruminous gland hyperplasia

c. Must treat aggressively

i. Prednisone

1. 2.2 mg/kg divided BID for at least 3 to 14 days then decreasing over time.

II. Topical steroids

1. Fluocinolone (Synotic®)

IX. Otitis Media

a. In one large study 42% of the dogs with otitis media were Cockers.

b. The exuberant inflammation in the outer canal causes inflammation in the tympanic bulla.

i. This leads to a decrease in the normal ciliary cells of the middle ear lining and an increase in the goblet cells which form mucin glands.

ii. The mucin formed by theses altered glands can form polymer chains and is much more viscous than normal middle ear fluid.

c. The exuberant inflammation in the outer canal causes a loss or reversal of epidermal migration. This can result in:

i. Rupture of the tympanic membrane

II. Formation of cholesteatomas

d. Diagnosis

i. Radiology

1. In end stage ears plain radiographs miss at least 25 to 33% of histopathologically confirmed otitis media.

2. This percentage is even higher when non-end stage ears are examined

3. CT and MRI are better than plain radiographs

4. Ultrasound is not as good as plain radiographs

II. Deep ear cleaning

1. Should be delayed until the inflammation has been decreased and the canal is open.

2. Assessment of the tympanic membrane

a. Visualization

b. Disappearance of tube

c. Excessive use of fluid

d. Patient swallowing during flushing

e. Curette catching on bony prominence

III. Myringotomy

1. When to do

a. Otitis greater than 3 months duration

b. Bulging or cloudy tympanic membrane

c. Fluid or debris behind the tympanic membrane

2. Where to perform

a. In the caudal ventral quadrant of the tympanum

IV. Assessment of tympanic bulla

1. Normally has sheen like a joint synovium and feels like bone.

2. Check for granulation tissue formation.

3. Cholesteatoma formation.

v. Hazards of deep ear cleaning and myringotomy

1. Horner's syndrome

2. Vestibular/ auditory dysfunction

3. Contact allergic reactions

4. Introduction of pathogens into the middle ear

e. Treatment

i. Aggressive and complete

II. Culture both external and middle ears when

1. Rods on cytology

2. Failure to respond to therapy

3. Greater than 3 months duration of disease

4. Value of culturing is debated

III. Pseudomonas culture/sensitivity

1. In a recent study polymyxin B(100%), gentamicin (85%) and enrofloxacin (62%) were the best antibiotic choices for Pseudomonas.

2. Kirby Bauer vs. MIC

a. Some Pseudomonas resistant to enrofloxacin on Kirby Bauer were sensitive on MIC

b. On Kirby Bauer, need to have individual discs for ciprofloxacin, enrofloxacin, and marbofloxacin

IV. Antibiotic Therapy

1. Incorporates both systemic and topical therapy

2. At home flushing is a vital part of therapy

3. Multi-drug therapy is recommended for Pseudomonas

a. Use antibiotics that have different routes of uptake and different mechanisms of action so that development of resistance is more difficult.

4. Topical therapy

a. T8® solution (tris-EDTA), let sit in ear 10-15 minutes, then put in antibiotic solution

b. Tris-EDTA increases penetration of antibiotics through Pseudomonas cell wall

c. Neomycin/polymyxin B/hydrocortisone

d. Gentamicin

e. Baytril/ dexamethasone/ saline (4cc, 1cc, 5cc)

5. Systemic therapy

a. Should be based on results of culture/sensitivity (if resistant to one of the fluoroquinolones, soon will be resistant to all)

b. Enrofloxacin (15-20 mg/kg daily)

c. Ciprofloxacin (12-22 mg/kg daily)

d. Marbofloxacin (5-7 mg/kg daily)

e. Prednisone as needed to open ear canal.

X. Maintenance Program

a. Owners usually cannot stop flushing completely.

b. Use a strong ceruminolytic and drying agent that is also acidic.

c. Long term topical steroid therapy may also be necessary.

Xi. Other Options

a. Cyclosporine

b. Retinoids

c. DMSO

d. Laser

Related Content:

Dermatology
Comparing treatments for restoring the skin barrier in atopic dogs
Comparing treatments for restoring the skin barrier in atopic dogs
Exploring molecular allergology as the future of allergy testing and immunotherapy
Exploring molecular allergology as the future of allergy testing and immunotherapy
dvm360® is seeking nominations for the 2023 Veterinary Heroes Awards
dvm360® is seeking nominations for the 2023 Veterinary Heroes Awards

Advertisement

Latest News

Comparing treatments for restoring the skin barrier in atopic dogs

Increasing efficiency and productivity in uncertain times

AAVMC awards almost $100,000 in diversity scholarships

News wrap-up: This week’s headlines, plus Maryland Zoo welcomes baby addra gazelle

View More Latest News
Advertisement